The page you are about to visit contains information about Viatris that is specific to Spain. Regulatory requirements, data protection requirements and practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.
The page you are about to visit contains information about Viatris that is specific to . Regulatory requirements, data protection requirements and
practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.
Mylan is now part of Viatris, a new global pharmaceutical company committed to empowering people to live healthier at every stage of life. We encourage you to learn more about our
commitment to increasing access to quality medicines for patients when and where they need them.
You are now leaving the Viatris page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in
certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements
applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to
other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for
use in your country.
Viatris releases financial and regulatory documents to the public, including earnings information and filings to the United States Securities and Exchange Commission (SEC). Download these documents below.